{"id":"dextropropoxyphene","rwe":[],"tags":[{"label":"Opioid Agonist","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Mu-type opioid receptor","category":"target"},{"label":"OPRM1","category":"gene"},{"label":"GRIN3A","category":"gene"},{"label":"SCN5A","category":"gene"},{"label":"N02AC04","category":"atc"},{"label":"Oral","category":"route"},{"label":"Capsule","category":"form"},{"label":"Tablet","category":"form"},{"label":"Active","category":"status"},{"label":"Pain","category":"indication"},{"label":"Approved 1950s","category":"decade"},{"label":"Analgesics","category":"pharmacology"},{"label":"Analgesics, Opioid","category":"pharmacology"},{"label":"Central Nervous System Agents","category":"pharmacology"},{"label":"Central Nervous System Depressants","category":"pharmacology"},{"label":"Narcotics","category":"pharmacology"},{"label":"Peripheral Nervous System Agents","category":"pharmacology"},{"label":"Sensory System Agents","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":838.014,"date":"","count":289,"signal":"Drug hypersensitivity","source":"DrugCentral FAERS","actionTaken":"Reported 289 times (LLR=838)"},{"llr":218.938,"date":"","count":118,"signal":"Toxicity to various agents","source":"DrugCentral FAERS","actionTaken":"Reported 118 times (LLR=219)"},{"llr":74.819,"date":"","count":47,"signal":"Completed suicide","source":"DrugCentral FAERS","actionTaken":"Reported 47 times (LLR=75)"},{"llr":45.687,"date":"","count":46,"signal":"Drug interaction","source":"DrugCentral FAERS","actionTaken":"Reported 46 times (LLR=46)"}],"drugInteractions":[{"url":"/drug/rasagiline","drug":"rasagiline","action":"Avoid combination","effect":"May interact with Propoxyphene, Rasagiline","source":"DrugCentral","drugSlug":"rasagiline"},{"url":"/drug/ritonavir","drug":"ritonavir","action":"Monitor closely","effect":"May interact with Propoxyphene, Ritonavir","source":"DrugCentral","drugSlug":"ritonavir"},{"url":"/drug/selegiline","drug":"selegiline","action":"Avoid combination","effect":"May interact with Propoxyphene, Selegiline","source":"DrugCentral","drugSlug":"selegiline"},{"url":"/drug/sodium-oxybate","drug":"sodium oxybate","action":"Avoid combination","effect":"May interact with Propoxyphene, Sodium Oxybate","source":"DrugCentral","drugSlug":"sodium-oxybate"},{"url":"/drug/tranylcypromine","drug":"tranylcypromine","action":"Avoid combination","effect":"May interact with Propoxyphene, Tranylcypromine","source":"DrugCentral","drugSlug":"tranylcypromine"}],"commonSideEffects":[],"contraindications":["Acute erosive gastritis","Acute exacerbation of asthma","Acute nephropathy","Acute pancreatitis","Agoraphobia","Alcohol intoxication","Alcoholism","Anemia","Anemia due to enzyme deficiency","Breastfeeding (mother)","Central nervous system depression","Chronic obstructive lung disease","Conduction disorder of the heart","Congenital long QT syndrome","Cor pulmonale","Decreased respiratory function","Depressive disorder","Disease of liver","Disorder of biliary tract","Exacerbation of asthma","Factor II deficiency","Gastrointestinal hemorrhage","Gastrointestinal ulcer","Gout","Hemophilia"]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_fixedAt":"2026-03-30T16:52:23.910024","_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=dextropropoxyphene","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:02:01.537241+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T00:02:15.689536+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:02:06.948774+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=dextropropoxyphene","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:02:07.366727+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1213351/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:02:08.205688+00:00"}},"allNames":"propoxyphene compound 65","offLabel":[],"synonyms":["dextropropoxyphene","propoxyphene hydrochloride","dextropropoxyphen","propoxyphene","d-Propoxyphene","propoxyphene napsylate","propoxyphene HCl","destropropoxifene"],"timeline":[{"date":"1957-08-16","type":"positive","source":"DrugCentral","milestone":"FDA approval"}],"aiSummary":"Dextropropoxyphene (Propoxyphene Compound 65) is a marketed opioid analgesic used for pain management, with a key composition patent expiring in 2028. Its primary competitive advantage lies in its mechanism of action, which effectively binds to opioid receptors to provide pain relief. However, the primary risk is the strong competition from off-patent drugs like methadone, which has 13 generics available in the market.","approvals":[{"date":"1957-08-16","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Propoxyphene Compound 65","ecosystem":[{"indication":"Pain","otherDrugs":[{"name":"acetylsalicylic acid","slug":"acetylsalicylic-acid","company":"Endo Pharms"},{"name":"bromfenac","slug":"bromfenac","company":"Bausch And Lomb Inc"},{"name":"butorphanol","slug":"butorphanol","company":""},{"name":"caffeine","slug":"caffeine","company":"Novartis"}],"globalPrevalence":1500000000}],"mechanism":{"target":"Mu-type opioid receptor","novelty":"Follow-on","targets":[{"gene":"OPRM1","source":"DrugCentral","target":"Mu-type opioid receptor","protein":"Mu-type opioid receptor","isPrimary":true,"activityType":"","activityValue":null},{"gene":"GRIN3A","source":"DrugCentral","target":"Glutamate receptor ionotropic, NMDA 3A","protein":"Glutamate receptor ionotropic, NMDA 3A"},{"gene":"SCN5A","source":"DrugCentral","target":"Sodium channel protein type 5 subunit alpha","protein":"Sodium channel protein type 5 subunit alpha"}],"moaClass":"Full Opioid Agonists","modality":"Small Molecule","drugClass":"Opioid Agonist","explanation":"","oneSentence":"","technicalDetail":"Dextropropoxyphene acts as a mu-type opioid receptor agonist, activating G-protein coupled receptors to stimulate the release of neurotransmitters such as dopamine and endorphins, which are involved in pain modulation and reward processing."},"commercial":{"launchDate":"1957","_launchSource":"DrugCentral (FDA 1957-08-16, )"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/844","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=dextropropoxyphene","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=dextropropoxyphene","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:37:52.757158","_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T00:02:15.689645+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"methadone","drugSlug":"methadone","fdaApproval":"1947-08-13","genericCount":13,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"dextropropoxyphene","indications":{"approved":[{"name":"Pain","source":"DrugCentral","snomedId":22253000,"regulator":"FDA","eligibility":"adults and children over 12 years of age","usPrevalence":51600000,"globalPrevalence":1500000000,"prevalenceMethod":"curated","prevalenceSource":"CDC, 2023"}],"offLabel":[],"pipeline":[]},"_fixedFields":["primaryTarget"],"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"methadone","brandName":"methadone","genericName":"methadone","approvalYear":"1947","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT05635071","phase":"PHASE2,PHASE3","title":"Prospective Clinical Study of Nintedanib to Inhibit Endometrial Fibrosis to Prevent Recurrence of Uterine Adhesions","status":"UNKNOWN","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2023-12-01","conditions":["Uterine Adhesions"],"enrollment":90,"completionDate":"2024-12-30"},{"nctId":"NCT00652093","phase":"PHASE4","title":"Lumbar Stenosis Outcomes Research II","status":"TERMINATED","sponsor":"University of Rochester","startDate":"2008-03","conditions":["Lumbar Spinal Stenosis"],"enrollment":24,"completionDate":"2011-08"},{"nctId":"NCT00378937","phase":"PHASE4","title":"Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain","status":"COMPLETED","sponsor":"University Hospitals Bristol and Weston NHS Foundation Trust","startDate":"2004-01","conditions":["Pain","Unspecified Adult Solid Tumor, Protocol Specific"],"enrollment":30,"completionDate":"2006-02"},{"nctId":"NCT01133873","phase":"PHASE4","title":"Multiple-Ascending-Dose Study to Evaluate the Safety of Propoxyphene Napsylate In Healthy Adult Subjects","status":"TERMINATED","sponsor":"Xanodyne Pharmaceuticals","startDate":"2010-06","conditions":["Healthy"],"enrollment":48,"completionDate":"2010-11"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral","formulation":"Capsule, Tablet","formulations":[{"form":"CAPSULE","route":"ORAL","productName":"Propoxyphene"},{"form":"TABLET","route":"ORAL","productName":"PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN"},{"form":"TABLET, FILM COATED","route":"ORAL","productName":"PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN"},{"form":"TABLET, FILM COATED","route":"ORAL","productName":"Propoxyphene Napsylate and Acetaminophen"},{"form":"TABLET, FILM COATED","route":"ORAL","productName":"Propoxyphene and Acetaminophen"},{"form":"TABLET, FILM COATED","route":"ORAL","productName":"Darvon-N"}]},"crossReferences":{"NUI":"N0000148000","MMSL":"2224","NDDF":"001574","UNII":"CB2TL9PS0T","VUID":"4019915","CHEBI":"CHEBI:51173","VANDF":"4017511","INN_ID":"740","RXNORM":"71517","UMLSCUI":"C0033493","chemblId":"CHEMBL1213351","ChEMBL_ID":"CHEMBL1237104","KEGG_DRUG":"D00482","DRUGBANK_ID":"DB00647","PUBCHEM_CID":"10100","SNOMEDCT_US":"117005003","IUPHAR_LIGAND_ID":"7593","SECONDARY_CAS_RN":"1639-60-7","MESH_DESCRIPTOR_UI":"D011431","MESH_SUPPLEMENTAL_RECORD_UI":"C084813"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","halfLife":"18.0 hours","clearance":"15.0 mL/min/kg","fractionUnbound":"0.24%","volumeOfDistribution":"12.0 L/kg"},"publicationCount":559,"therapeuticAreas":["Pain"],"atcClassification":{"source":"DrugCentral","atcCode":"N02AC04","allCodes":["N02AC04","N02AC54","N02AC74"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"1957","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":"1957-08-16T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":"1957-08-16T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":"1957-08-16T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":"1957-08-16T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"SA","regulator":"SFDA","status":"likely_approved","approval_date":"1957-08-16T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1957-08-16T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T00:02:15.689645+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}